These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6207821)

  • 1. Inhibition of guanylate cyclases by methylxanthines and papaverine.
    Strinden ST; Stellwagen RH
    Biochem Biophys Res Commun; 1984 Sep; 123(3):1194-200. PubMed ID: 6207821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex effects of inhibitors on cyclic GMP-stimulated cyclic nucleotide phosphodiesterase.
    Yamamoto T; Yamamoto S; Osborne JC; Manganiello VC; Vaughan M; Hidaka H
    J Biol Chem; 1983 Dec; 258(23):14173-7. PubMed ID: 6196360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of particulate and soluble guanylate cyclases from rat lung.
    Chrisman TD; Garbers DL; Parks MA; Hardman JG
    J Biol Chem; 1975 Jan; 250(2):374-81. PubMed ID: 234425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caffeine and related methylxanthines: possible naturally occurring pesticides.
    Nathanson JA
    Science; 1984 Oct; 226(4671):184-7. PubMed ID: 6207592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isobutylmethylxanthine stimulates adenylate cyclase by blocking the inhibitory regulatory protein, Gi.
    Parsons WJ; Ramkumar V; Stiles GL
    Mol Pharmacol; 1988 Jul; 34(1):37-41. PubMed ID: 2455859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of phosphodiesterase inhibitors, imidazole and phosphate on cyclic CMP phosphodiesterase are different from those on cyclic AMP and cyclic GMP phosphodiesterases.
    Kuo JF; Shoji M; Brackett NL; Helfman DM
    J Cyclic Nucleotide Res; 1978 Dec; 4(6):463-74. PubMed ID: 85641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rapid method for the assay of guanylate cyclase.
    Krishna G; Krishnan N
    J Cyclic Nucleotide Res; 1975; 1(6):293-302. PubMed ID: 5469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential inhibition of phosphodiesterase according to the organ origin of the enzyme.
    Uzunov P; Petkov V; Stancheva S
    Acta Neurobiol Exp (Wars); 1975; 35(2):159-64. PubMed ID: 170801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The absence of stimulation of lipolysis by papaverine, a strong inhibitor of phosphodiesterase.
    Hynie S; Wenke M
    Eur J Pharmacol; 1975 Feb; 30(2):230-7. PubMed ID: 165081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and vectorial export of cGMP in airway epithelium: expression of soluble and CNP-specific guanylate cyclases.
    Geary CA; Goy MF; Boucher RC
    Am J Physiol; 1993 Dec; 265(6 Pt 1):L598-605. PubMed ID: 7506495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two effects of phosphodiesterase inhibitors on Limulus ventral photoreceptors.
    Corson DW; Fein A; Schmidt J
    Brain Res; 1979 Nov; 176(2):365-8. PubMed ID: 91407
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of thiol inhibitors on hepatic guanylate cylase activity.
    Craven PA; DeRubertis FR
    Biochim Biophys Acta; 1978 May; 524(1):231-44. PubMed ID: 26412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actions of various methylxanthines and papaverine on the synthesis of corticosterone in vitro.
    Vapaatalo H; Neuvonen PJ; Bieck P; Westermann E
    Arzneimittelforschung; 1975 Aug; 25(8):1265-9. PubMed ID: 170947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of particulate, membrane-associated and soluble guanylate cyclase from cardiac muscle, skeletal muscle, cerebral cortex and liver.
    Sulakhe SJ; Leung NL; Sulakhe PV
    Biochem J; 1976 Sep; 157(3):713-9. PubMed ID: 10891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of mammalian soluble guanylate cyclase activity by adenosine 5'-tetraphosphate, guanosine 5'-tetraphosphate and other nucleotides.
    Ignarro LJ; Gross RA; Gross DM
    J Cyclic Nucleotide Res; 1976; 2(5):337-46. PubMed ID: 12193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectors of rat lung cGMP binding protein-phosphodiesterase.
    Francis SH
    Curr Top Cell Regul; 1985; 26():247-62. PubMed ID: 2416513
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of calcium-blocking agents and phosphodiesterase inhibitors on voltage-dependent conductances in Limulus photoreceptors.
    Schmidt JA; Fein A
    Brain Res; 1979 Nov; 176(2):369-74. PubMed ID: 91408
    [No Abstract]   [Full Text] [Related]  

  • 18. Occurrence of the methylisobutylxanthine-stimulated cyclic GMP binding protein in various rat tissues.
    Coquil JF; Brunelle G; Guédon J
    Biochem Biophys Res Commun; 1985 Feb; 127(1):226-31. PubMed ID: 2579651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mechanism of soluble guanylate cyclase stimulation: time-dependent activation by bacterial lipopolysaccharide in rat fetal spleen cells.
    Graber SE; Clancey MA; Wells JN; Gerzer R
    Biochim Biophys Acta; 1988 Dec; 972(3):331-8. PubMed ID: 2461743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic formation of inosine 3',5'-monophosphate and of 2'-deoxyguanosine 3',5'-monophosphate. Inosinate and deoxyguanylate cyclase activity.
    Garbers DL; Suddath JL; Hardman JG
    Biochim Biophys Acta; 1975 Jan; 377(1):174-85. PubMed ID: 235291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.